Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis

Meyeon Park1, Michael G Shlipak, Ronit Katz

  • 1Division of Nephrology, Department of Medicine, University of California, San Francisco, CA 94121, USA. meyeon.park@ucsf.edu

Insights

Subclinical cardiac abnormalities, specifically concentricity, are linked to faster kidney function decline. This association persists even when accounting for common risk factors like diabetes and hypertension.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiovascular Imaging

Background:

  • Clinical heart failure (HF) is linked to chronic kidney disease (CKD) and accelerated kidney function loss.
  • The relationship between subclinical cardiac structural abnormalities and kidney function decline is not well understood.

Purpose of the Study:

  • To evaluate the association between cardiac concentricity and kidney function decline.
  • To investigate if abnormal cardiac structure predicts faster decline in estimated glomerular filtration rate (eGFR) and incident CKD.

Main Methods:

  • Longitudinal analysis of 3866 individuals from the Multi-Ethnic Study of Atherosclerosis (2000-2007).
  • Cardiac concentricity assessed via magnetic resonance imaging.
  • Kidney function measured by estimated GFR (eGFRcr and eGFRcys); statistical models adjusted for demographics, BP, diabetes, and inflammatory markers.

Main Results:

  • Individuals in the highest quartile of cardiac concentricity experienced an additional 21% decline in mean eGFRcr compared to the lowest quartile.
  • Cardiac concentricity was significantly associated with incident CKD.
  • Higher concentricity correlated with rapid kidney function decline (>5% per year).

Conclusions:

  • Subclinical cardiac structural abnormalities are independently associated with longitudinal kidney function decline.
  • These findings highlight a potential link between cardiac health and kidney preservation, independent of common comorbidities.
  • Further research is warranted to elucidate the underlying mechanisms driving this association.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...